Daniel Lindén
Impact in
- Biochemistry top 1%
- Lipid metabolism and biosynthesis
-
- Diet, Metabolism, and Disease
Papers in
-
- Peroxisome Proliferator-Activated Receptors 14
- Epidemiology 18
- Liver Disease Diagnosis and Treatment 14
- Co-authors
- Jan Oscarsson (19 shared papers)Stefano Romeo (6 shared papers)Lena William‐Olsson (6 shared papers)Mikael Bjursell (9 shared papers)Andrea Ahnmark (10 shared papers)Mohammad Bohlooly‐Y (11 shared papers)Anna Ljungberg (6 shared papers)Lennart Asp (4 shared papers)
- Journals
- American Journal of Physiology-Endocrinology and Metabolism (6 papers)Journal of Lipid Research (4 papers)PLoS ONE (4 papers)Liver International (3 papers)Diabetes (3 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Daniel Lindén
53 papers receiving 2.5k citations
Daniel Lindén's Hit Papers
Peers
Comparison fields: 5 of 111
- Biochemistry 365
- Endocrinology, Diabetes and Metabolism 484
- Endocrine and Autonomic Systems 176
- Epidemiology 849
- Hepatology 171
Countries citing papers authored by Daniel Lindén
This map shows the geographic impact of Daniel Lindén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lindén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lindén more than expected).
Fields of papers citing papers by Daniel Lindén
This network shows the impact of papers produced by Daniel Lindén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lindén. The network helps show where Daniel Lindén may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Lindén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 225 | |
| 2 | 2017 | 156 | |
| 3 | 2006 | 138 | |
| 4 | 2020 | 123 | |
| 5 | 2004 | 114 | |
| 6 | 2002 | 113 | |
| 7 | 2019 | 108 | |
| 8 | 2006 | 104 | |
| 9 | 2004 | 89 | |
| 10 | 2019 | 87 | |
| 11 | 2005 | 83 | |
| 12 | 2023 | 81 | |
| 13 | 2002 | 79 | |
| 14 | 2005 | 71 | |
| 15 | 2019 | 66 | |
| 16 | 2014 | 64 | |
| 17 | 2001 | 62 | |
| 18 | 2013 | 61 | |
| 19 | 2016 | 54 | |
| 20 | PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein Hit paper breakdown → | 2024 | 52 |
About Daniel Lindén
Daniel Lindén is a scholar working on Molecular Biology, Epidemiology, Endocrinology, Diabetes and Metabolism, Physiology and Surgery, having authored 53 papers that have together received 2.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (14 papers), Peroxisome Proliferator-Activated Receptors (14 papers), Adipose Tissue and Metabolism (11 papers), Lipid metabolism and biosynthesis (6 papers), Lipid metabolism and disorders (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Pancreatic function and diabetes (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). The work is most often cited by research in Biochemistry (365 citations), Endocrinology, Diabetes and Metabolism (484 citations), Endocrine and Autonomic Systems (176 citations), Epidemiology (849 citations) and Hepatology (171 citations). Daniel Lindén has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Jan Oscarsson, Stefano Romeo, Lena William‐Olsson, Mikael Bjursell, Andrea Ahnmark, Mohammad Bohlooly‐Y, Anna Ljungberg, Lennart Asp, Caroline Améen and Sven‐Olof Olofsson. Their work appears in journals such as American Journal of Physiology-Endocrinology and Metabolism, Journal of Lipid Research, PLoS ONE, Liver International and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.